Advertisement

Pembrolizumab/Trametinib vs Gemcitabine in Addition to SBRT for Pancreatic Cancer
Posted: 04/01/2022 | By: Melissa E. Fryman, MS

Question 1 of 5

About __% of patients with surgically resected pancreatic cancer experience a local recurrence.

Choose 1

A
45%
B
50%
C
55%
D
60%

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage